Search

Medtronic PLC

Ouvert

SecteurSoins de santé

104.64 -0.34

Résumé

Variation du prix de l'action

24h

Actuel

Min

103.62

Max

106.07

Chiffres clés

By Trading Economics

Revenu

206M

1.5B

Ventes

-51M

9.8B

P/E

Moyenne du Secteur

23.697

51.78

BPA

1.45

Rendement du dividende

2.95

Marge bénéficiaire

15.16

Employés

95,000

EBITDA

47M

2.7B

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

-1.69% downside

Dividendes

By Acuity

Rendement du dividende

Moyenne du Secteur

2.95%

1.96%

Prochains Résultats

17 nov. 2026

Date du Prochain Dividende

15 janv. 2027

Date du Prochain Détachement de Dividende

25 déc. 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

11B

127B

Ouverture précédente

104.98

Clôture précédente

104.64

Medtronic PLC Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

4 nov. 2026, 23:01 UTC

Medtronic PLC shares are declining in after-market trading, having retraced from a brief high to a significant low since Wednesday's close.

3 nov. 2026, 23:01 UTC

Medtronic PLC shares are trading modestly lower in after-market hours, having retraced from a high point shortly after the market closed.

2 nov. 2026, 23:01 UTC

Medtronic PLC shares traded modestly lower during after-market hours on Monday, ending a recent trend of higher daily closes.

31 oct. 2026, 00:01 UTC

Medtronic PLC shares are trading modestly lower in after-market hours, declining from an early peak.

30 oct. 2026, 23:41 UTC

Medtronic PLC shares are modestly lower in after-market trading, continuing a notable decline from earlier peaks shortly after the market closed.

29 oct. 2026, 23:03 UTC

Medtronic PLC shares are advancing in after-market trading, supported by a strong Health Care Equipment sub-sector performance since Thursday's close.

28 oct. 2026, 23:02 UTC

Medtronic PLC shares advanced in after-market hours, reflecting a modest increase since Wednesday's close and remaining near the upper end of its one-month range.

27 oct. 2026, 23:01 UTC

Medtronic PLC shares traded modestly lower during after-market hours on Tuesday, marking a decline over four consecutive sessions.

26 oct. 2026, 22:41 UTC

Medtronic PLC shares are trading modestly lower in after-market hours.

23 oct. 2026, 23:01 UTC

Medtronic PLC shares advanced in after-market trading, supported by a notable rise in the Health Care Equipment sub-sector.

22 oct. 2026, 23:41 UTC

Event

Medtronic PLC announced positive real-world registry results for its Affera™ Mapping and Ablation System and Sphere-9™ Catheter, along with the PulseSelect™ PFA System.

21 oct. 2026, 20:02 UTC

News

Medtronic PLC shares declined sharply, retracing from an early high and hitting a mid-afternoon low, amid high market volume.

20 oct. 2026, 21:03 UTC

Medtronic PLC shares are trading modestly lower in after-market hours, having retraced from a brief high shortly after the market closed.

19 oct. 2026, 23:01 UTC

News

Medtronic PLC appointed Michael Marinaro as President, effective October 14, 2026, with a $1M salary and $3.25M in long-term incentives.

16 oct. 2026, 20:07 UTC

Medtronic PLC shares are modestly lower, following a broader market decline of nearly three-quarters of a percent since Thursday's close.

15 oct. 2026, 20:07 UTC

News

Medtronic PLC completed the separation of MiniMed Group, Inc., exchanging 252.81M shares of MiniMed for 55.03M of its own ordinary shares.

14 oct. 2026, 23:01 UTC

Medtronic PLC shares are trading lower in after-market hours, having pulled back from earlier gains, now near the lower end of today’s range.

13 oct. 2026, 23:01 UTC

Medtronic PLC shares declined in after-market hours, reversing from earlier gains to a modest loss since Tuesday's close.

12 oct. 2026, 22:01 UTC

Medtronic PLC shares are trading modestly lower in after-market hours, having retraced from earlier gains.

9 oct. 2026, 21:01 UTC

Medtronic PLC shares are trading modestly higher in after-market hours, following a pullback earlier in the session and three consecutive sessions of gains.

8 oct. 2026, 23:05 UTC

Medtronic PLC saw a modest increase in after-market trading, recovering from earlier lows while remaining below its 20-day moving average.

7 oct. 2026, 22:51 UTC

News

Medtronic PLC announced an exchange ratio of 4.5939 shares of MiniMed Group, Inc. stock for each ordinary share, contributing to a modest gain in after-market trading.

6 oct. 2026, 22:40 UTC

Medtronic PLC is recovering in after-market trading, rising sharply from Tuesday's close and reaching its highest level of the day, despite remaining below its 20-day moving average.

5 oct. 2026, 21:01 UTC

Medtronic PLC traded roughly flat during after-market hours, closing near the lower end of its one-month range and below its 20-day moving average.

3 oct. 2026, 00:00 UTC

Medtronic PLC shares traded modestly higher in after-market hours on Friday, recovering from a brief dip and remaining near the lower end of their one-month trading range.

2 oct. 2026, 23:00 UTC

Medtronic PLC is advancing in after-market trading, showing a modest increase since Friday's close, with significant upward movement shortly after the market reopened.

1 oct. 2026, 22:01 UTC

News

Medtronic PLC shares are higher in after-market trading following the approval of new CPT codes for its Altaviva and Symplicity Spyral devices, effective January 2028.

30 sept. 2026, 23:01 UTC

Medtronic PLC is trading modestly higher in after-market hours, reflecting broader market trends amid positive economic indicators and stronger-than-expected private sector job growth.

29 sept. 2026, 20:02 UTC

Medtronic PLC shares fell sharply today, reversing a trend of higher daily closes, amid unusually high trading volume and broader market trends.

28 sept. 2026, 23:16 UTC

Medtronic PLC is trading slightly lower in after-market hours, remaining below its 20-day moving average and near the lower end of its one-month range.

Comparaison

Variation de prix

Medtronic PLC prévision

Objectif de Prix

By TipRanks

-1.69% baisse

Prévisions sur 12 Mois

Moyen 103.188 USD  -1.69%

Haut 118 USD

Bas 85 USD

Basé sur 19 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

19 ratings

10

Achat

9

Maintien

0

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Medtronic PLC

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists; and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat other non-exclusive diseases and conditions; and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems, and InPen, a smart insulin pen system. The company was founded in 1949 and is headquartered in Galway, Ireland.
help-icon Live chat